SRX246: Completed Phase II enrollment

Azevan completed enrollment of 96 patients in a double-blind,

Read the full 93 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE